Elisa Uliassi

2.2k total citations · 1 hit paper
43 papers, 1.6k citations indexed

About

Elisa Uliassi is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Elisa Uliassi has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Organic Chemistry and 10 papers in Pharmacology. Recurrent topics in Elisa Uliassi's work include Cholinesterase and Neurodegenerative Diseases (10 papers), Computational Drug Discovery Methods (7 papers) and Synthesis and Biological Evaluation (7 papers). Elisa Uliassi is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (10 papers), Computational Drug Discovery Methods (7 papers) and Synthesis and Biological Evaluation (7 papers). Elisa Uliassi collaborates with scholars based in Italy, Brazil and Germany. Elisa Uliassi's co-authors include María Laura Bolognesi, Marija R. Popović-Nikolić, Rona R. Ramsay, Katarina Nikolić, Federica Prati, Maria Paola Costi, Marinella Roberti, Rafael Luque, Manuela Bartolini and Francesco Mauriello and has published in prestigious journals such as Chemical Society Reviews, SHILAP Revista de lepidopterología and Advanced Drug Delivery Reviews.

In The Last Decade

Elisa Uliassi

41 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A perspective on multi‐target drug discovery and design for complex diseases

2018 527 citations Elisa Uliassi, María Laura Bolognesi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisa Uliassi Italy	19	639	441	438	400	175	43	1.6k
Marina Naldi Italy	24	606 0.9×	352 0.8×	228 0.5×	228 0.6×	278 1.6×	73	1.5k
Zheying Zhu United Kingdom	25	906 1.4×	443 1.0×	242 0.6×	787 2.0×	180 1.0×	87	2.1k
Manish Tripathi India	19	349 0.5×	357 0.8×	358 0.8×	210 0.5×	148 0.8×	93	1.4k
Opa Vajragupta Thailand	22	677 1.1×	354 0.8×	178 0.4×	413 1.0×	269 1.5×	82	1.8k
Amirhossein Sakhteman Iran	23	468 0.7×	596 1.4×	539 1.2×	916 2.3×	68 0.4×	106	1.8k
Rajnish Kumar India	22	658 1.0×	212 0.5×	329 0.8×	417 1.0×	138 0.8×	95	1.5k
Jinhyuk Lee South Korea	28	827 1.3×	259 0.6×	190 0.4×	156 0.4×	204 1.2×	120	2.1k
Daniel I. Pérez Spain	31	1.4k 2.2×	823 1.9×	339 0.8×	597 1.5×	499 2.9×	83	2.8k
Giovanni Ribaudo Italy	23	683 1.1×	257 0.6×	166 0.4×	380 0.9×	62 0.4×	121	1.5k
Angela De Simone Italy	29	859 1.3×	937 2.1×	626 1.4×	489 1.2×	556 3.2×	87	2.2k

Countries citing papers authored by Elisa Uliassi

Since Specialization

Citations

This map shows the geographic impact of Elisa Uliassi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Uliassi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Uliassi more than expected).

Fields of papers citing papers by Elisa Uliassi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Uliassi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Uliassi. The network helps show where Elisa Uliassi may publish in the future.

Co-authorship network of co-authors of Elisa Uliassi

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Uliassi. A scholar is included among the top collaborators of Elisa Uliassi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Uliassi. Elisa Uliassi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Uliassi, Elisa, María Laura Bolognesi, & Andrea Milelli. (2025). Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies. ACS Pharmacology & Translational Science. 8(3). 654–672. 5 indexed citations

Uliassi, Elisa, et al.. (2025). New Therapeutic Modalities in Prion Diseases. Sub-cellular biochemistry. 112. 39–64.

Uliassi, Elisa, et al.. (2025). Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting. Advanced Drug Delivery Reviews. 223. 115621–115621.

Diamanti, Eleonora, et al.. (2025). Medicinal Chemistry: A Key Driver in Achieving the Global Sustainable Development Goals. Journal of Medicinal Chemistry. 68(7). 6916–6931. 2 indexed citations

Greco, Giulia, Elisa Tassinari, Christian Bergamini, et al.. (2024). Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer. RSC Medicinal Chemistry. 15(6). 2045–2062. 1 indexed citations

Lima, Clara, Elisa Uliassi, Eli S.J. Thoré, et al.. (2024). Environmental impacts of drugs against parasitic vector-borne diseases and the need to integrate sustainability into their development and use. SHILAP Revista de lepidopterología. 4. 207–207. 1 indexed citations

Exertier, Cécile, Alessandra Salerno, Annarita Fiorillo, et al.. (2024). Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis. Journal of Medicinal Chemistry. 67(1). 402–419. 7 indexed citations

Fernandes, João Paulo S., et al.. (2024). Tackling Neuroinflammation in Cognitive Disorders with Single-targeted and Multi-targeted Histamine H3 Receptor Modulators. Current Topics in Medicinal Chemistry. 24(28). 2421–2430. 1 indexed citations

Pasieka, Anna, Eleonora Diamanti, Elisa Uliassi, & María Laura Bolognesi. (2023). Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists?. ChemMedChem. 18(20). e202300422–e202300422. 19 indexed citations

10.

Pruccoli, Letizia, Angela De Simone, Francesca Spyrakis, et al.. (2023). PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease. ACS Chemical Neuroscience. 14(11). 1963–1970. 19 indexed citations

11.

Uliassi, Elisa, Christian Bergamini, Nicola Rizzardi, et al.. (2023). Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease. Bioorganic & Medicinal Chemistry. 91. 117419–117419. 12 indexed citations

12.

Lauriola, Angela, Elisa Uliassi, Matteo Santucci, et al.. (2022). Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library. Pharmaceutics. 14(2). 391–391. 2 indexed citations

13.

Salerno, Alessandra, Francesca Seghetti, Elisa Uliassi, et al.. (2022). Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One. Journal of Medicinal Chemistry. 65(14). 9507–9530. 34 indexed citations

14.

Salerno, Alessandra, et al.. (2022). Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery. PubMed. 3(1). 32–45. 25 indexed citations

15.

Espro, Claudia, Emilia Paone, Francesco Mauriello, et al.. (2021). Sustainable production of pharmaceutical, nutraceutical and bioactive compounds from biomass and waste. Chemical Society Reviews. 50(20). 11191–11207. 149 indexed citations

16.

Górecki, Lukáš, Elisa Uliassi, Manuela Bartolini, et al.. (2021). Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer’s Disease. ACS Chemical Neuroscience. 12(9). 1698–1715. 19 indexed citations

17.

Uliassi, Elisa, et al.. (2021). Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer’s Disease. Molecules. 26(18). 5441–5441. 10 indexed citations

18.

Uliassi, Elisa, Giulia Fiorani, R. Luise Krauth‐Siegel, et al.. (2017). Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase ( Tb GAPDH) and Trypanosoma cruzi trypanothione reductase ( Tc TR) and display trypanocidal activity. European Journal of Medicinal Chemistry. 141. 138–148. 25 indexed citations

19.

Uliassi, Elisa, Jan Korábečný, Ondřej Soukup, et al.. (2016). Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease. European Journal of Medicinal Chemistry. 127. 250–262. 85 indexed citations

20.

Kiselev, Evgeny, Рамачандран Баласубраманиан, Elisa Uliassi, et al.. (2015). Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y14 receptor. Bioorganic & Medicinal Chemistry Letters. 25(21). 4733–4739. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact